1. [Coronavirus infection and risk of postoperative venous thromboembolic events].
- Author
-
Butyrskii AG, Mikhaylichenko VY, Golomidov AN, Khilko SS, Bobkov OV, Aliev AS, Rumyantseva MI, and Butyrskaya IB
- Subjects
- Humans, Incidence, Postoperative Complications diagnosis, Postoperative Complications epidemiology, Postoperative Complications etiology, Prospective Studies, Retrospective Studies, Risk Factors, Coronavirus Infections, Pulmonary Embolism diagnosis, Pulmonary Embolism epidemiology, Pulmonary Embolism etiology, Venous Thromboembolism diagnosis, Venous Thromboembolism epidemiology, Venous Thromboembolism etiology, Venous Thrombosis etiology
- Abstract
Objective: To determine whether patients with perioperative or previous coronavirus infection (CVI) have a greater risk of venous thromboembolic events ( VTE)., Material and Methods: A multiple-center regional prospective retrospective cohort study included elective and emergency patients who underwent surgery in November 2020. The primary endpoint was VTE (PE/DVT) within 30 days after surgery. CVI was stratified as perioperative (7 days before surgery - 30 days after surgery), recent (1-6 weeks before surgery) and remote (≥7 weeks before surgery) infection. There was no information about prevention or preoperative anticoagulation at baseline data collection., Results: Incidence of postoperative VTE was 1.5% (10/650) in patients without CVI, 33.3% (3/9) in patients with perioperative CVI, 18.1% (2/11) in patients with recent CVI and 8.3% (1/12) in patients with remote CVI. After adjusting the confounders, patients with perioperative and recent CVI remained at a higher risk of VTE. In general, VTEs were independently associated with 30-day mortality. In patients with CVI, mortality rate among ones without VTE was 21.7% (5/23), with VTE - 44.4% (4/9)., Conclusion: Patients with perioperative CVI have a higher risk of postoperative VTE compared to those without CVI and patients with previous CVI and no residual symptoms. Mortality in this group is also higher than in other cohorts.
- Published
- 2022
- Full Text
- View/download PDF